Cargando…
Use of ribavirin in viruses other than hepatitis C. A review of the evidence()
Ribavirin is a molecule with antiviral activity against different viruses. In clinical practice, it has made its niche almost exclusively for the treatment of the hepatitis C virus. However, there are other diseases in which it could be of benefit and it has the advantage of being suitable for oral,...
Autores principales: | Ramírez-Olivencia, German, Estébanez, Miriam, Membrillo, Francisco Javier, Ybarra, Maria del Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195261/ https://www.ncbi.nlm.nih.gov/pubmed/29907366 http://dx.doi.org/10.1016/j.eimce.2018.05.018 |
Ejemplares similares
-
Uso de ribavirina en virus distintos de la hepatitis C. Una revisión de la evidencia
por: Ramírez-Olivencia, German, et al.
Publicado: (2019) -
The Impact of Antibiotic Prophylaxis on a Retrospective Cohort of Hospitalized Patients with COVID-19 Treated with a Combination of Steroids and Tocilizumab
por: Membrillo de Novales, Francisco Javier, et al.
Publicado: (2023) -
Sensitivity of a Ribavirin Resistant Mutant of Hepatitis C Virus to Other Antiviral Drugs
por: Mihalik, Kathleen B., et al.
Publicado: (2013) -
Selection of hepatitis C virus resistant to ribavirin
por: Feigelstock, Dino A, et al.
Publicado: (2011) -
304. Impact of Antibiotic Prophylaxis Prior to Treatment with Steroids and Tocilizumab in COVID-19 Patients
por: de Novales, Francisco Javier Membrillo, et al.
Publicado: (2021)